11 results on '"Lopman, Ben"'
Search Results
2. Norovirus Infection and Disease in an Ecuadorian Birth Cohort: Association of Certain Norovirus Genotypes With Host FUT2 Secretor Status.
- Author
-
Lopman, Ben A., Trivedi, Tarak, Vicuña, Yosselin, Costantini, Veronica, Collins, Nikail, Gregoricus, Nicole, Parashar, Umesh, Sandoval, Carlos, Broncano, Nely, Vaca, Maritza, Chico, Martha E., Vinjé, Jan, and Cooper, Philip J.
- Subjects
- *
NOROVIRUS diseases , *GENOTYPES , *SECRETOR system (Physiology) , *FUCOSYLTRANSFERASES , *BLOOD group antigens ,IMMUNE system physiology - Abstract
Background. Although norovirus is the most common cause of gastroenteritis, there are few data on the community incidence of infection/disease or the patterns of acquired immunity or innate resistance to norovirus. Methods. We followed a community-based birth cohort of 194 children in Ecuador with the aim to estimate (1) the incidence of norovirus gastroenteritis from birth to age 3 years, (2) the protective effect of norovirus infection against subsequent infection/disease, and (3) the association of infection and disease with FUT2 secretor status. Results. Over the 3-year period, we detected a mean of 2.26 diarrheal episodes per child (range, 0-12 episodes). Norovirus was detected in 260 samples (18%) but was not found more frequently in diarrheal samples (79 of 438 [18%]), compared with diarrhea-free samples (181 of 1016 [18%]; P = .919). A total of 66% of children had at least 1 norovirus infection during the first 3 years of life, and 40% of children had 2 infections. Previous norovirus infections were not associated with the risk of subsequent infection. All genogroup II, genotype 4 (GII.4) infections were among secretor-positive children (P < .001), but higher rates of non-GII.4 infections were found in secretor-negative children (relative risk, 0.56; P = .029). Conclusions. GII.4 infections were uniquely detected in secretor-positive children, while non-GII.4 infections were more often found in secretor-negative children. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
3. Association of serum antibodies with protection against rotavirus infection and disease in South Indian children.
- Author
-
Premkumar, Prasanna, Lopman, Ben, Ramani, Sasirekha, Paul, Anu, Gladstone, Beryl, Muliyil, Jayaprakash, Mukhopadhya, Indrani, Parashar, Umesh, and Kang, Gagandeep
- Subjects
- *
BLOOD proteins , *IMMUNOGLOBULINS , *ROTAVIRUS diseases , *EPIDEMIOLOGY , *IMMUNOGLOBULIN G , *JUVENILE diseases , *INDIGENOUS peoples of the Americas , *DISEASES , *COHORT analysis , *PREVENTION - Abstract
Serum antibodies play an important role in natural protection from rotavirus infection and disease, but conflicting estimates of association have emerged from epidemiological studies in different geographical settings. In this study, we aim to assess the relationship between pre-existing serum immunoglobulin (Ig)G and IgA titers with protection against rotavirus infection and disease in a birth cohort of Indian children. Children were recruited at birth and followed up for 36 months. Stool samples were collected every 2 weeks and during episodes of diarrhea and serum samples were obtained at least every 6 months. The incidence rate of rotavirus infection and diarrhea was 0.9 (95% CI: 0.88, 0.99) and 0.2 (95% CI: 0.19, 0.25) episodes per child year, respectively. The risk of rotavirus infection and diarrhea decreased with age, while antibody titers (IgG and IgA) increased with age. After adjusting for age and number of previous infections, higher levels of IgG and IgA were independently associated with reduced risk of rotavirus infection. However, we did not find a clear association of IgG or IgA with rotavirus diarrhea risk or a threshold level of protection. The study supports a correlation of serum antibodies in reducing the risk of rotavirus infections, however the potential of serum antibody titer as a correlate of protection is not clear for children in lower income settings. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
4. Epidemiologic Implications of Asymptomatic Reinfection: A Mathematical Modeling Study of Norovirus.
- Author
-
Lopman, Ben, Simmons, Kirsten, Gambhir, Manoj, Vinjé, Jan, and Parashar, Umesh
- Subjects
- *
CLINICAL pathology , *AGE distribution , *COMPUTER simulation , *IMMUNITY , *MEDICAL cooperation , *POPULATION geography , *RESEARCH , *DISEASE relapse , *SECONDARY analysis , *DISEASE incidence , *DISEASE prevalence , *CASE-control method , *ENTEROBACTERIACEAE diseases , *NOROVIRUS diseases , *SYMPTOMS , *INFECTIOUS disease transmission - Abstract
The pathogenicity of norovirus is definitively established. However, norovirus is frequently detected in the stool of healthy individuals. To gain understanding of the apparent high prevalence of asymptomatic infection, we analyzed a dynamic transmission model of norovirus infection, disease, and immunity. We simulated norovirus epidemiology in low- and high-transmission settings by varying the basic reproduction number (R0). We predicted annual disease incidence values in children aged 0–4 years of 25% with a low R0 and 29% with a high R0. However, the point prevalence of asymptomatic infection rose sharply from 3% to 48% from the low to high R0 settings. Among older children and adults, the models projected that incidence of disease would rise from 6% to 16% from the low to high R0 settings, whereas asymptomatic infection prevalence was lower in this age group. Asymptomatic prevalence of norovirus can change dramatically with small changes in R0. The ratio of prevalence in cases to controls could be high in a developed country and close to or even less than 1 in a high-exposure setting, despite similar disease incidence. These findings highlight an important limitation of case-control studies for pathogens for which there is suboptimal diagnostic specificity. [ABSTRACT FROM PUBLISHER]
- Published
- 2014
- Full Text
- View/download PDF
5. Duration of Immunity to Norovirus Gastroenteritis.
- Author
-
Simmons, Kirsten, Gambhir, Manoj, Leon, Juan, and Lopman, Ben
- Subjects
IMMUNITY ,NOROVIRUSES ,NOROVIRUS diseases ,VIRAL gastroenteritis - Abstract
The duration of immunity to norovirus (NoV) gastroenteritis has been believed to be from 6 months to 2 years. However, several observations are inconsistent with this short period. To gain better estimates of the duration of immunity to NoV, we developed a mathematical model of community NoV transmission. The model was parameterized from the literature and also fit to age-specific incidence data from England and Wales by using maximum likelihood. We developed several scenarios to determine the effect of unknowns regarding transmission and immunity on estimates of the duration of immunity. In the various models, duration of immunity to NoV gastroenteritis was estimated at 4.1 (95% CI 3.2-5.1) to 8.7 (95% CI 6.8-11.3) years. Moreover, we calculated that children (<5 years) are much more infectious than older children and adults. If a vaccine can achieve protection for duration of natural immunity indicated by our results, its potential health and economic benefits could be substantial. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
6. A Systematic Review of Anti-Rotavirus Serum IgA Antibody Titer as a Potential Correlate of Rotavirus Vaccine Efficacy.
- Author
-
Patel, Manish, Glass, Roger I., Jiang, Baoming, Santosham, Mathuram, Lopman, Ben, and Parashar, Umesh
- Subjects
ROTAVIRUS diseases ,SYSTEMATIC reviews ,ANTIVIRAL agents ,SERUM ,IMMUNOGLOBULIN A ,ROTAVIRUS vaccines ,DRUG efficacy ,THERAPEUTICS - Abstract
Background. Identifying an immunological correlate of protection for rotavirus vaccines (Rotarix [RV1] and RotaTeq [RV5]) would substantially facilitate testing of interventions for improving efficacy in developing countries and evaluating additional candidate rotavirus vaccines.Methods. We accessed PubMed and ClinicalTrials.gov to identify immunogenicity and efficacy trials for RV1 and RV5 to correlate anti-rotavirus serum immunoglobulin A (IgA) antibody titers vs efficacy in regions stratified by all-cause under-5 mortality rates (u5MR). We established a cutoff point for IgA geometric mean concentration or titer (GMC) that predicted lower efficacy and calculated pooled vaccine efficacy among countries with high vs low IgA titers.Findings. We observed an inverse correlation between u5MR and IgA titers for RV1 (r2 = 0.72; P < .001 and RV5 (r2 = 0.66; P < .001) and between efficacy and IgA titers for both vaccines (r2 = 0.56; P = .005). Postimmunization anti-rotavirus IgA GMC <90 were associated with decline in vaccine efficacy. Efficacy during first 2 years of life was significantly lower among countries with IgA GMC < 90 (44%; 95% confidence interval [CI], 30–55) compared to countries with GMC > 90 (85%; 95% CI, 82–88).Interpretation. We observed a significant correlation between IgA titers and rotavirus vaccine efficacy and hypothesize that a critical level of IgA antibody titer is associated with a sufficient level of sustained protection after rotavirus vaccination. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
7. Household Transmission of Rotavirus in a Community with Rotavirus Vaccination in Quininde, Ecuador.
- Author
-
Lopman, Ben, Vicuña, Yosselin, Salazar, Fabian, Broncano, Nely, Esona, Matthew D., Sandoval, Carlos, Gregoricus, Nicole, Bowen, Michael D., Payne, Daniel, Vaca, Martiza, Chico, Martha, Parashar, Umesh, and Cooper, Philip J.
- Subjects
- *
ROTAVIRUSES , *VIRAL transmission , *CITIES & towns , *FECAL analysis , *DIARRHEA prevention , *ROTAVIRUS vaccines , *POLYMERASE chain reaction , *EPIDEMIOLOGY - Abstract
Background: We studied the transmission of rotavirus infection in households in peri-urban Ecuador in the vaccination era. Methods: Stool samples were collected from household contacts of child rotavirus cases, diarrhea controls and healthy controls following presentation of the index child to health facilities. Rotavirus infection status of contacts was determined by RT-qPCR. We examined factors associated with transmissibility (index-case characteristics) and susceptibility (household-contact characteristics). Results: Amongst cases, diarrhea controls and healthy control household contacts, infection attack rates (iAR) were 55%, 8% and 2%, (n = 137, 130, 137) respectively. iARs were higher from index cases with vomiting, and amongst siblings. Disease ARs were higher when the index child was <18 months and had vomiting, with household contact <10 years and those sharing a room with the index case being more susceptible. We found no evidence of asymptomatic infections leading to disease transmission. Conclusion: Transmission rates of rotavirus are high in households with an infected child, while background infections are rare. We have identified factors associated with transmission (vomiting/young age of index case) and susceptibility (young age/sharing a room/being a sibling of the index case). Vaccination may lead to indirect benefits by averting episodes or reducing symptoms in vaccinees. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
8. Editorial Commentary: In Praise of Birth Cohorts: Norovirus Infection, Disease, and Immunity.
- Author
-
Lopman, Ben and Kang, Gagandeep
- Subjects
- *
NOROVIRUS diseases , *NOROVIRUSES , *COHORT analysis , *EPIDEMIOLOGY , *PUBLIC health , *IMMUNITY - Abstract
The authors explore the importance of birth cohorts in understanding norovirus infection, epidemiology and immunity. They note on the importance of birth cohort studies in understanding the acquisition of protective immunity against a pathogen. They mention a birth cohort study in Mexico which showed that severe disease is restricted to the first 2 infections, that each infection reduces future disease risk.
- Published
- 2014
- Full Text
- View/download PDF
9. In Praise of Birth Cohorts: Norovirus Infection, Disease, and Immunity.
- Author
-
Lopman, Ben and Kang, Gagandeep
- Published
- 2013
- Full Text
- View/download PDF
10. RNA Populations in Immunocompromised Patients as Reservoirs for Novel Norovirus Variants.
- Author
-
Vega, Everardo, Donaldson, Eric, Huynh, Jeremy, Barclay, Leslie, Lopman, Ben, Baric, Ralph, Chen, Luke F., and Vinjé, Jan
- Subjects
- *
RNA , *IMMUNOCOMPROMISED patients , *NOROVIRUSES , *GASTROENTERITIS , *EPIDEMICS , *IMMUNITY , *BIOINFORMATICS , *BIOLOGICAL evolution - Abstract
Noroviruses are the leading cause of acute gastroenteritis outbreaks worldwide. The majority of norovirus outbreaks are caused by genogroup II.4 (GII.4). Novel GII.4 strains emerge every 2 to 4 years and replace older variants as the dominant norovirus. Novel variants emerge through a combination of recombination, genetic drift, and selection driven by population immunity, but the exact mechanism of how or where is not known. We detected two previously unknown novel GII.4 variants, termed GII.4 UNK1 and GII.4 UNK2, and a diverse norovirus population in fecal specimens from immunocompromised individuals with diarrhea after they had undergone bone marrow transplantation. We hypothesized that immunocompromised individuals can serve as reservoirs for novel norovirus variants. To test our hypothesis, metagenomic analysis of viral RNA populations was combined with a full-genome bioinformatic analysis of publicly available GII.4 norovirus sequences from 1974 to 2014 to identify converging sites. Variable sites were proportionally more likely to be within two amino acids (P<0.05) of positively selected sites. Further analysis using a hypergeometric distribution indicated that polymorphic site distribution was random and its proximity to positively selected sites was dependent on the size of the norovirus genome and the number of positively selected sites. In conclusion, random mutations may have a positive impact on driving norovirus evolution, and immunocompromised individuals could serve as potential reservoirs for novel GII.4 strains. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
11. The impact of indirect benefits of vaccination on postlicensure vaccine effectiveness estimates: A scenario analysis
- Author
-
Patel, Manish M., Tate, Jacqueline, Cortese, Margaret, Payne, Daniel C., Armstrong, Greg, Parashar, Umesh D., and Lopman, Ben
- Subjects
- *
DRUG efficacy , *VACCINES , *RANDOMIZED controlled trials , *COHORT analysis , *IMMUNITY , *ESTIMATES , *POPULATION health , *MATHEMATICAL models in medicine - Abstract
Abstract: Vaccine efficacy is measured in randomized, prelicensure clinical trials where vaccination typically affords only direct protection to the vaccinated individual. Vaccine effectiveness is measured in postlicensure observational studies where vaccination might provide indirect benefits to a population as a whole in addition to directly protecting the vaccinated individual. The potential discrepancy in effectiveness and efficacy estimates would depend on the postlicensure study design. We developed a mathematical model to assess the impact of indirect benefits on vaccine effectiveness as measured by the common cohort study design under scenarios of homogenous and heterogenous vaccine allocation. We found that under the cohort design, effectiveness estimates equaled efficacy if either the indirect effects were assumed to be negligible or vaccine allocation in the community was homogenous. However, in presence of indirect benefits, effectiveness estimates would be biased upward compared with vaccine efficacy if one of the two sub-populations in the same study had a higher rate of vaccination. Because of indirect effects of vaccination, even in studies where other biases can be eliminated, the presence of distinct sub-populations with varying rates of vaccination can lead to discrepancies between effectiveness and efficacy estimates. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.